Toine Pieters
Toine Pieters
Unknown affiliation
Verified email at uu.nl
Title
Cited by
Cited by
Year
Interferon: The science and selling of a miracle drug
T Pieters
Routledge, 2005
642005
Neonatal screening for treatable and untreatable disorders: prospective parents’ opinions
AMC Plass, CG van El, T Pieters, MC Cornel
Pediatrics 125 (1), e99-e106, 2010
612010
Addressing the challenge of high-priced prescription drugs in the era of precision medicine: a systematic review of drug life cycles, therapeutic drug markets and regulatory …
T Gronde, CA Uyl-de Groot, T Pieters
PLoS One 12 (8), e0182613, 2017
572017
Gene doping: an overview and current implications for athletes
T van der Gronde, O de Hon, HJ Haisma, T Pieters
British Journal of Sports Medicine 47 (11), 670-678, 2013
562013
Cultural enthusiasm, resistance and the societal embedding of new technologies: psychotropic drugs in the 20th century
FW Geels, T Pieters, S Snelders
Technology Analysis & Strategic Management 19 (2), 145-165, 2007
552007
Big data for global history: The transformative promise of digital humanities
J Eijnatten, T Pieters, J Verheul
BMGN-Low Countries Historical Review 128 (4), 55-77, 2013
492013
On cannabis, chloral hydrate, and career cycles of psychotropic drugs in medicine
S Snelders, C Kaplan, T Pieters
Bulletin of the History of Medicine, 95-114, 2006
452006
Psychotropic drug use: Between healing and enhancing the mind
T Pieters, S Snelders
Neuroethics 2 (2), 63-73, 2009
422009
Neurobiological correlates in forensic assessment: a systematic review
T Van der Gronde, M Kempes, C van El, T Rinne, T Pieters
PLoS One 9 (10), e110672, 2014
372014
A 10-year analysis of the effects of media coverage of regulatory warnings on antidepressant use in The Netherlands and UK
JF Hernandez, AK Mantel-Teeuwisse, GJMW Van Thiel, SV Belitser, ...
PLoS One 7 (9), e45515, 2012
332012
Marketing medicines through randomised controlled trials: the case of interferon
T Pieters
Bmj 317 (7167), 1231-1233, 1998
311998
Speed in the Third Reich: metamphetamine (Pervitin) use and a drug history from below
S Snelders, T Pieters
Social history of medicine 24 (3), 686-699, 2011
302011
Genetic screening and democracy: lessons from debating genetic screening criteria in the Netherlands
CG van El, T Pieters, M Cornel
Journal of Community Genetics 3 (2), 79-89, 2012
292012
From King Kong pills to mother’s little helpers—career cycles of two families of psychotropic drugs: the barbiturates and benzodiazepines
T Pieters, S Snelders
Canadian Bulletin of Medical History 24 (1), 93-112, 2007
282007
Effective pharmaceutical regulation needs alignment with doctors
HC Ebbers, T Pieters, HG Leufkens, H Schellekens
Drug discovery today 17 (3-4), 100-103, 2012
242012
Ethical and social issues in pharmacogenomics testing
SJH Vijverberg, T Pieters, MC Cornel
Current pharmaceutical design 16 (2), 245-252, 2010
242010
Systematic review of the mechanisms and evidence behind the hypocholesterolaemic effects of HPMC, pectin and chitosan in animal trials
T van der Gronde, A Hartog, C van Hees, H Pellikaan, T Pieters
Food chemistry 199, 746-759, 2016
232016
A digital humanities approach to the history of science
P Huijnen, F Laan, M De Rijke, T Pieters
International Conference on Social Informatics, 71-85, 2013
212013
Semantic document selection
D Odijk, O De Rooij, MH Peetz, T Pieters, M De Rijke, S Snelders
International Conference on Theory and Practice of Digital Libraries, 215-221, 2012
212012
Interferon and its first clinical trial: looking behind the scenes
T Pieters
Medical history 37 (3), 270-295, 1993
211993
The system can't perform the operation now. Try again later.
Articles 1–20